Latham & Watkins and Cleary Gottlieb Steen & Hamilton have scored prize mandates on one of the biggest pharmaceutical deals of the year, as Actavis has agreed to buy Botox-maker Allergan in a $66bn (£42bn) cash and shares deal.
November 17, 2014 at 12:05 PM
1 minute read
The original version of this story was published on Legalweek
Latham & Watkins and Cleary Gottlieb Steen & Hamilton have scored the prize mandates on one of the biggest pharmaceutical deals of the year, as Actavis has agreed to buy Botox-maker Allergan for $66bn (£42bn) in cash and shares.
The sale is expected to close in the second quarter of 2015, creating one of the world’s 10 biggest pharmaceutical companies with annual revenues close to $23bn (£14.7bn).
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
